The Center for Technology Licensing's (CTL) mission is to bring the University's scientific discoveries, technological innovations, and medical advances to the marketplace for societal benefit and to foster economic development within New York State and across the nation.
Licensing
CTL is industry's link to Cornell's broad range of innovative research that is available for licensing. Over the years, Cornell technologies have been licensed to industry partners all over the world in support of Cornell's land-grant mission and to develop these technologies and plant varieties into products and services for public good.
Available Cornell Technologies
- Novel Ubiquibodies⢠for Selective Protein Silencing
- Pseudo-Lidar from Visual Depth Estimation for 3D Object Detection
- Low-resistance Ohmic Edge Contacts between Two-dimensional Materials for Large-scale Atomically-thin Circuitry
- Operation Dependent Frequency Scaling Using Desynchronization
- Gene Therapy for Oxidative Stress
- Non-precious Metal-based Complexes Used as Efficient Hydrosilylation Catalysts
Current Featured Technologies
- » Generic Programmable Tag
- » Red Wine Grape ‘Arandell’
- » White Wine Grape ‘Aromella’
- » Reversible Small Molecule Immunoproteasome Inhibitors
- » Tethered Enzyme Technology (TET™) Point-of-Care Testing for Brain Injuries
- » Accommodating Intraocular Lens & Conversion Plate
- » Biomarkers for Predicting & Diagnosing Cancer/Metastasis